Sequencing of SARS-CoV-2 - first update
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on which technologies to use and/or in deciding on the role of sequencing for SARS-CoV-2 diagnostics, research, outbreak investigations and surveillance.
External quality assessment (EQA) schemes to support European surveillance of Legionnaires’ disease 2019-2020 - EU/EEA countries
This report provides an analysis of the EQA performance of laboratories in the 28 EU/EEA countries in relation to the detection/isolation, identification, enumeration and quantification of Legionella spp. and the further characterisation of L. pneumophila, by serogrouping and sequence-based typing, from both clinical and environmental samples, where applicable.
Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018
Leitmeyer, K.C., Espinosa, L., Broberg, E.K., Struelens, M.J.
Influenza virus characterisation - Summary Europe, June 2020
This is the eighth report for the 2019–20 influenza season. As of week 25/2020, 164 883 influenza detections across the WHO European Region had been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 479 (98%) of 4 568 ascribed to a lineage being B/Victoria.
Influenza virus characterisation - Summary Europe, May 2020
This is the seventh report for the 2019 2019–20 influenza season. As of week 20 / 16 4 868 influenza detections across the WHO European Region ha have been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 4 479 (98%) of 4 5 568 ascribed to a lineage being B/Victoria.
Surveillance of COVID-19 at long-term care facilities in the EU/EEA
It is of paramount importance to be able to rapidly identify, assess and control COVID-19 outbreaks in LTCFs in order to protect this particularly fragile population. This document provides guidance for EU/EEA Member States planning to implement monitoring systems at LTCFs and describes the surveillance objectives.
Influenza virus characterisation, summary Europe, April 2020
ECDC’s influenza virus characterisation reports are published periodically and give an overview of circulating influenza viruses. They provide details on the current vaccine strains, summarise the development of the viruses since the last report, and closely follow the main developments for the ongoing influenza season. Virus characterisation reports are primarily intended for influenza virologists and epidemiologists.
Weekly influenza update, week 8, February 2020
In collaboration with WHO Regional Office for Europe, ECDC monitors and reports on influenza activity in Europe on a weekly basis throughout the flu season.